Therapeutic applications of bone marrow-derived stem cells in liver transplantation for end-stage liver diseases

Today, liver transplantation (LT) is the only established treatment for end-stage liver diseases. The de- velopment of LT, including OLT, cadaveric LT, split LT, living donor LT (LDLT), brings hopes to patients with these diseases. However, increasing donor shortage, rejection and life-long immunosuppression with its side effects are the major limitations of this therapy strategy. Bone marrow-derived stem cells (BMDSCs) are capable of differentiating into hepatocyte-like cells and contribute to liver injury repair. The microenvironment of liver injury caused by rejection, ischemia/reperfusion, loss of liver mass, recurrence of HCV and "small-for-size syndrome" after LT can attract a variety of bone marrow-derived stem cell population to the peripheral circulation and then migration to the injury liver to promote the hepatic function restoration. Additionally, BMDSCs can also take part in the functional regeneration of living donor liver after LDLT. This participation in liver regeneration may be associated to the interac- tion between SDF-1and its receptor CXCR4, involving HGF, IL-8, MMP9, and VEGF/VEGFR-2. BMDSC with its bio-characteristics could maintain the allograft tolerance from different angles and in different ways. In conclusion, BMDSCs transplantation, as a new assistant therapeutic method for LT, will ex- pand the space of LT, and provide more survival opportunities for the patients suffering liver diseases in the future.     

Finding finer functions for partially characterized proteins by protein-protein interaction networks

Based on high-throughput data, numerous algorithms have been designed to find functions of novel proteins. However, the effectiveness of such algorithms is currently limited by some fundamental factors, including (1) the low a-priori probability of novel proteins participating in a detailed function; (2) the huge false data present in high-throughput datasets; (3) the incomplete data coverage of functional classes; (4) the abundant but heterogeneous negative samples for training the algorithms; and (5) the lack of detailed functional knowledge for training algorithms. Here, for partially characterized proteins, we suggest an approach to finding their finer functions based on protein interaction sub-networks or gene expression patterns, defined in function-specific subspaces. The proposed approach can lessen the above-mentioned problems by properly defining the prediction range and functionally filtering the noisy data, and thus can efficiently find proteins’ novel functions. For thousands of yeast and human proteins partially characterized, it is able to reliably find their finer functions (e.g., the translational functions) with more than 90% precision. The predicted finer functions are highly valuable both for guiding the follow-up wet-lab validation and for providing the necessary data for training algorithms to learn other proteins.     

高等学校污水再生利用的途径与效益研究

目的探讨高等学校污水再生利用的可行性。方法以陕西某高校为例,采用类比分析法和效益分析方法。结果某高校除去部分较难处理污水,如冲厕所产生污水、厨房污水等,可用污水为2 528 m3/d,占总污水量的67%,经处理后得到可用水约2 000 m3/d,完全满足该校区1 658 m3/d杂用水量的预算。该校区如果实施污水再生利用,每年可以节省绿化、洗车等杂水费用约52.2万元,20年收益为1 044万元。其污水再生处理工艺适合采用生物接触氧化法。结论在高等学校实施污水再生利用是必要的,而且技术是可行的。     

网络路由收敛性能测试研究

在网络建设和运行中,采用测试的方法对其性能进行评估对于网络的正常运营具有重要的意义.本文研究了网络路由收敛性能测试方法,为得到路由收敛性能指标,对OSPF和iBGP的路由收敛时间进行了测量.提出了一种简化的路由收敛时间测量方法,通过测量数据平面的传输性能指标,对路由控制平面的收敛时间进行估算.该方法对于测试设备要求不高,实施简单方便.采用该方法在CERNET2投入运营之前对其进行了路由性能测试,实验结果表明CERNET2在路由变化时具有较好的路由收敛性能.     

CGPSS-F仿真系统数据的采集与分析

本文详细地叙述了“医院门诊部为门诊病人服务的CGPSS-F仿真系统”数据采集与分析的方法.利用CGPSS-F仿真系统的驻留在队列中的实体数和资源处于繁忙状态的单元数,合理调整实体在系统的时间.根据资源容量的利用,实体排队的长度和实体在系统的时间,确定实用的系统参数.     

H—列闭空间与H—序列闭空间

本文引进了θ-聚点,II-列闭空间与II-序列闭空间的概念,并对II-可数闭空间、II-列闭空间、II-序列闭空间建立了一些关系.     

部分充满介质的理想螺线管条件

一般教科书中都提到，理想螺线管（指内部磁场均匀，无漏磁）的条件是无限长（相对而言），绕线蜂蜜。但对绕线是否应该均匀则未做详细论述。本文试图指出，在无介质情况下理想螺线管的绕线都是均匀的，但在部分充满介质的情况下，均匀的绕线反而会破坏“理想”的条件。     

均匀带电圆环的电势

从电势的一般概念出发得出均匀带电圆环的公式，并讨论在极限情况下约化为均匀带电细圆环的电势公式。